Selinexor (KPT-330) Induces Tumor Suppression Through Nuclear Sequestration of IκB and Downregulation of Survivin
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-16-2632
Full Text
Open PDFAbstract
Available in full text
Date
March 17, 2017
Authors
Publisher
American Association for Cancer Research (AACR)